Liver Transplantation Basics — MCQs
Solution currently used for liver preservation for transplantation is?
Which of the following statements regarding rejection of solid organ transplants is true?
What is the documented mortality rate for healthy liver donors undergoing donor hepatectomy?
Which of the following is an indication of auxiliary partial orthotopic liver transplantation?
According to the DSM-5 criteria for Autism Spectrum Disorder, which of the following is required for diagnosis in children?
All are Indications of liver transplant except
What organism causes emphysematous cholecystitis?
Which of the following does not contribute to the formation of an enterobiliary fistula?
Klatskin tumor is defined as:
Which of the following is NOT a tumor marker for hepatocellular carcinoma?
Liver Transplantation Basics Indian Medical PG Practice Questions and MCQs
Question 1: Solution currently used for liver preservation for transplantation is?
- A. IGL-1 solution
- B. Ross Marshall Citrate solution
- C. University of Wisconsin (UW) solution (Correct Answer)
- D. Kyoto ET solution
Explanation: ***University of Wisconsin (UW) solution*** - The **University of Wisconsin (UW) solution** is widely considered the gold standard for **organ preservation**, particularly for liver transplantation, due to its superior ability to extend cold ischemia time. - It contains a unique blend of components, including **lactobionate, raffinose, and hydroxyethyl starch**, which help to minimize cellular swelling, prevent free radical injury, and maintain cellular integrity during cold storage. *IGL-1 solution* - **IGL-1** is a more recent preservation solution designed to be used with **machine perfusion** systems. - While showing promise, it is **not yet as universally adopted** as UW solution for static cold storage of livers. *Ross Marshall Citrate solution* - The **Ross Marshall Citrate solution** was an older solution primarily used for **kidney preservation**. - It has been largely **superseded by newer solutions** with improved efficacy for liver and other organ preservation. *Kyoto ET solution* - **Kyoto ET solution** is another preservation solution primarily used in **Japan**, particularly for **kidney and pancreas preservation**. - While effective for those organs, it is **not the most commonly used** or preferred solution for liver preservation globally.
Question 2: Which of the following statements regarding rejection of solid organ transplants is true?
- A. Most immunosuppressive medications are used to prevent chronic rejection
- B. The major cause of graft failure is acute rejection
- C. Liver transplants are especially susceptible to hyperacute rejection
- D. Hyperacute rejection begins in the operating room with reperfusion of the transplanted organ (Correct Answer)
Explanation: ***Hyperacute rejection begins in the operating room with reperfusion of the transplanted organ*** - **Hyperacute rejection** is a rapidly-occurring immune response that starts almost immediately after the transplanted organ is re-vascularized, often while the patient is still in the operating room [1]. - This type of rejection is mediated by **pre-formed antibodies** (e.g., ABO blood group antibodies or anti-HLA antibodies) in the recipient's circulation that bind to antigens on the donor organ's endothelium, leading to massive thrombosis and organ destruction [1]. *Most immunosuppressive medications are used to prevent chronic rejection* - While immunosuppressants play a role in mitigating **chronic rejection**, their primary and most effective targets are **acute rejection episodes** and the initial prevention of organ rejection [2]. - **Chronic rejection** is often a more complex process involving both immune and non-immune factors, and current immunosuppressive regimens are less effective at completely preventing or reversing it compared to acute rejection. *The major cause of graft failure is acute rejection* - In the long term, **chronic rejection** (or chronic allograft dysfunction) is the leading cause of late graft loss, rather than acute rejection. - With advancements in immunosuppression, **acute rejection rates** have significantly decreased, making chronic issues and non-immune factors more prominent in overall graft failure. *Liver transplants are especially susceptible to hyperacute rejection* - **Liver transplants** are notably more tolerant to ABO and HLA mismatches compared to other solid organ transplants (like kidney or heart). - This relative immunotolerance means that **hyperacute rejection** is far less common in liver transplantation. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 241-242. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 180-181.
Question 3: What is the documented mortality rate for healthy liver donors undergoing donor hepatectomy?
- A. Mortality for donor is 0.6 to 0.8 %
- B. Mortality for donor is 0.5 %
- C. Mortality for donor is 0.2 to 0.4 % (Correct Answer)
- D. Mortality for donor is 1%
Explanation: ***Correct: Mortality for donor is 0.2 to 0.4%*** - Studies indicate that the **mortality rate** for healthy liver donors undergoing **donor hepatectomy** is very low, typically ranging from **0.2% to 0.4%**. - This rate reflects the extensive **pre-operative screening** and careful surgical techniques used to ensure donor safety. - Current data from major transplant centers worldwide support this range as the most accurate representation of donor risk. *Incorrect: Mortality for donor is 0.6 to 0.8%* - This range is **higher** than the generally accepted and documented mortality rates for healthy liver donors. - While complications can occur, fatal outcomes are rare, making this percentage an **overestimation** of actual risk. *Incorrect: Mortality for donor is 0.5%* - This mortality rate is also **higher** than the current reported rates for living liver donation in well-established centers. - Continuous advancements in surgical safety and donor selection have driven the mortality rate **below 0.5%** in most high-volume centers. *Incorrect: Mortality for donor is 1%* - A 1% mortality rate for healthy liver donors would be considered **unacceptably high** given the current standards of care. - This percentage severely **overestimates** the actual risks associated with living related liver donation and does not reflect modern surgical outcomes.
Question 4: Which of the following is an indication of auxiliary partial orthotopic liver transplantation?
- A. As a standby procedure till a suitable donor is found
- B. Metabolic liver disease (Correct Answer)
- C. Drug induced hepatic failure
- D. All irreversible causes of fulminant liver failure
Explanation: ***Metabolic liver disease*** - **Auxiliary partial orthotopic liver transplantation (APOLT)** is indicated for metabolic liver diseases to provide the necessary enzyme or protein function while potentially allowing the native liver to regenerate. - This procedure involves transplanting a portion of a healthy liver and leaving a portion of the diseased native liver in place. This is especially useful in conditions like **Crigler-Najjar syndrome** or **urea cycle disorders**. *As a standby procedure till a suitable donor is found* - While temporary support can be crucial in acute liver failure, APOLT is a complex surgical procedure, not a simple standby. - **Bridge to transplant** often involves less invasive measures like extracorporeal liver assist devices rather than a partial transplant. *Drug induced hepatic failure* - Drug-induced hepatic failure, if reversible, typically managed with supportive care, and the native liver may recover. - While severe cases might require transplantation, APOLT is generally reserved for conditions requiring ongoing metabolic support where the native liver may eventually recover some function. *All irreversible causes of fulminant liver failure* - For irreversible **fulminant liver failure**, a **full orthotopic liver transplantation** is usually required because the entire native liver needs to be replaced due to extensive and irreversible damage. - APOLT aims to allow the native liver to recover, which is unlikely in cases of irreversible fulminant failure, making a complete replacement necessary.
Question 5: According to the DSM-5 criteria for Autism Spectrum Disorder, which of the following is required for diagnosis in children?
- A. Language delay before age 2
- B. Persistent deficits in social communication and interaction (Correct Answer)
- C. Presence of seizure disorder
- D. Intellectual disability
Explanation: ***Persistent deficits in social communication and interaction*** - This is a **core diagnostic criterion** for Autism Spectrum Disorder (ASD) according to DSM-5, encompassing difficulties in social-emotional reciprocity, nonverbal communicative behaviors, and developing/maintaining relationships. - These deficits must be present across **multiple contexts** and not better explained by other conditions. *Language delay before age 2* - While language delay is common in ASD, it is **not a mandatory diagnostic criterion** in the DSM-5; some individuals with ASD may have typical or even advanced language skills. - The focus has shifted from specific language milestones to broader **social communication deficits**. *Presence of seizure disorder* - **Seizures** are a co-occurring medical condition that can affect individuals with ASD, but they are absolutely **not a diagnostic criterion** for the disorder itself. - The presence of a seizure disorder suggests comorbidity, not a defining feature of autism. *Intellectual disability* - **Intellectual disability** frequently co-occurs with ASD (approximately 30-50% of cases), but it is **not a required criterion** for diagnosis. - Many individuals with ASD have average or above-average intellectual abilities.
Question 6: All are Indications of liver transplant except
- A. Biliary atresia
- B. Cirrhosis
- C. Fulminant hepatitis
- D. Cholangiocarcinoma (Correct Answer)
Explanation: ***Cholangiocarcinoma*** - **Cholangiocarcinoma** is a **contraindication** for liver transplantation due to its aggressive nature and high recurrence rate post-transplant, except in highly selected early cases treated with neoadjuvant therapy. - The risk of **tumor recurrence** and poor long-term survival generally outweighs the benefits of transplantation for this malignancy. *Biliary atresia* - **Biliary atresia** is the most common indication for **pediatric liver transplantation**. - It involves the progressive destruction of bile ducts, leading to **cholestasis**, cirrhosis, and liver failure in infants. *Cirrhosis* - **Cirrhosis** from various etiologies (e.g., viral hepatitis, alcohol, NASH) is a primary indication for liver transplantation when it leads to **decompensated liver disease** or end-stage liver failure. - Patients with complications like **ascites**, **encephalopathy**, or recurrent variceal bleeding often require transplant. *Fulminant hepatitis* - **Fulminant hepatitis** (acute liver failure) rapidly progresses to severe liver dysfunction and encephalopathy in individuals without pre-existing liver disease. - It is an urgent indication for **emergent liver transplantation** to prevent multi-organ failure and death.
Question 7: What organism causes emphysematous cholecystitis?
- A. Salmonella typhi
- B. Cytomegalovirus
- C. Clostridium perfringens (Correct Answer)
- D. Bacteroides
Explanation: **Explanation:** **Emphysematous cholecystitis** is a severe, life-threatening variant of acute cholecystitis characterized by the presence of gas within the gallbladder wall, lumen, or pericholecystic tissues. **Why Clostridium perfringens is correct:** The primary pathophysiology involves **ischemia** of the gallbladder wall (often due to cystic artery compromise), which creates an anaerobic environment. This allows gas-forming organisms to proliferate. **Clostridium perfringens** is the most common anaerobic organism isolated. It produces gas through the fermentation of glucose, leading to the characteristic radiographic finding of "gas shadows" on X-ray or CT. Other common isolates include *E. coli* and *Klebsiella*. **Why the other options are incorrect:** * **Salmonella typhi:** Associated with chronic carrier states in the gallbladder and "typhoid cholecystitis," but it is not a gas-forming organism and does not cause emphysematous changes. * **Cytomegalovirus (CMV):** Typically causes cholecystitis in immunocompromised patients (e.g., AIDS) as part of CMV polyradiculopathy or acalculous cholecystitis, but not emphysematous disease. * **Bacteroides:** While *Bacteroides fragilis* can be found in polymicrobial intra-abdominal infections, it is a less common primary driver of emphysematous cholecystitis compared to Clostridia. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** Strongly associated with **Diabetes Mellitus** (found in >30-50% of cases) and the elderly. * **Gender:** Unlike typical cholecystitis, it is more common in **males** (M:F ratio 3:1). * **Acalculous:** It is frequently acalculous (stones are absent in up to 30% of cases). * **Complications:** High risk of **gangrene and perforation** (5x higher than routine cholecystitis). * **Management:** Emergency cholecystectomy is the treatment of choice.
Question 8: Which of the following does not contribute to the formation of an enterobiliary fistula?
- A. Duodenal ulcer
- B. Gall stones
- C. Gastric ulcer (Correct Answer)
- D. Carcinoma of the gallbladder
Explanation: **Explanation:** An enterobiliary fistula is an abnormal communication between the biliary tree and the gastrointestinal tract. The formation of such a fistula requires the offending organ to be in direct anatomical proximity to the gallbladder or common bile duct. **Why Gastric Ulcer is the Correct Answer:** The stomach (specifically the body and fundus) is not anatomically adherent to the gallbladder. While the pylorus and antrum are nearby, **gastric ulcers** typically occur on the lesser curvature and do not usually lead to biliary fistulization. In contrast, the duodenum and the transverse colon are the most common sites for these communications. **Analysis of Other Options:** * **Gallstones (Option B):** This is the **most common cause** (90% of cases). Chronic inflammation and pressure necrosis from a large stone lead to erosion through the gallbladder wall into an adjacent organ, most commonly the duodenum (cholecystoduodenal fistula). * **Duodenal Ulcer (Option A):** A posterior or superior wall duodenal ulcer can erode into the common bile duct or gallbladder, creating a fistula. This is the second most common cause after gallstones. * **Carcinoma of the Gallbladder (Option D):** Malignant infiltration can cause direct breakdown of the tissue planes between the gallbladder and the duodenum or colon, resulting in a malignant fistula. **NEET-PG High-Yield Pearls:** * **Most common type:** Cholecystoduodenal fistula (70%), followed by cholecystocolic. * **Rigler’s Triad (Pathognomonic for Gallstone Ileus):** 1. Pneumobilia (air in the biliary tree), 2. Small bowel obstruction, 3. Ectopic gallstone (usually in the ileum). * **Bouveret Syndrome:** A rare presentation where a large gallstone migrates through a fistula and causes gastric outlet obstruction.
Question 9: Klatskin tumor is defined as:
- A. Primitive neuroectodermal tumor in the chest
- B. Cholangiocarcinoma arising from the bifurcation of the bile duct (Correct Answer)
- C. Lung adenocarcinoma involving the apical region
- D. Enterochromaffin cell tumor
Explanation: ### Explanation **Correct Answer: B. Cholangiocarcinoma arising from the bifurcation of the bile duct** **Understanding Klatskin Tumor:** A Klatskin tumor is a specific type of **hilar cholangiocarcinoma** (extrahepatic bile duct cancer) that originates at the junction of the right and left hepatic ducts. Because of its strategic location at the biliary bifurcation, it typically presents early with **painless obstructive jaundice**. On imaging, it is characterized by the "non-union" of the right and left hepatic ducts. **Analysis of Incorrect Options:** * **Option A:** A primitive neuroectodermal tumor (PNET) occurring specifically in the chest wall is known as a **Askin tumor**, not Klatskin. * **Option C:** A lung adenocarcinoma (or squamous cell carcinoma) involving the apex of the lung, often causing Horner’s syndrome or brachial plexus palsy, is called a **Pancoast tumor**. * **Option D:** Enterochromaffin cell tumors are **Carcinoid tumors**, which arise from the neuroendocrine system, most commonly in the appendix or terminal ileum. **High-Yield Clinical Pearls for NEET-PG:** * **Bismuth-Corlette Classification:** This is the staging system used to define the anatomical extent of Klatskin tumors (Type I to IV). * **Risk Factors:** Primary Sclerosing Cholangitis (PSC) is the most common predisposing factor in the West; Choledochal cysts and *Clonorchis sinensis* infection are also significant. * **Diagnosis:** MRCP is the gold standard for non-invasive imaging to visualize the biliary tree. * **Tumor Marker:** **CA 19-9** is frequently elevated and used for monitoring. * **Management:** Surgical resection (often involving hemihepatectomy) is the only curative intent treatment, though many patients are unresectable at the time of diagnosis.
Question 10: Which of the following is NOT a tumor marker for hepatocellular carcinoma?
- A. AFP
- B. PIVKA II
- C. CEA (Correct Answer)
- D. Glypican-3
Explanation: **Explanation:** The correct answer is **CEA (Carcinoembryonic Antigen)**. CEA is a non-specific oncofetal antigen primarily used as a tumor marker for **colorectal carcinoma**, as well as pancreatic, gastric, and breast cancers. While it may be elevated in liver metastases from these sites, it is not a diagnostic marker for primary hepatocellular carcinoma (HCC). **Analysis of Options:** * **AFP (Alpha-Fetoprotein):** The most widely used screening and diagnostic marker for HCC. Levels >400 ng/mL in a high-risk patient (e.g., cirrhosis) are highly suggestive of HCC. * **PIVKA-II (Protein Induced by Vitamin K Absence or Antagonist-II):** Also known as Des-gamma-carboxyprothrombin (DCP). It is highly specific for HCC and is often used in combination with AFP to increase diagnostic sensitivity, especially in AFP-negative cases. * **Glypican-3 (GPC3):** A cell-surface heparan sulfate proteoglycan that is overexpressed in HCC cells but absent in healthy hepatocytes and benign liver lesions. It is an excellent immunohistochemical marker for differentiating HCC from dysplastic nodules. **Clinical Pearls for NEET-PG:** * **Triple Marker Screening:** Some protocols use the "BALAD score" (Bilirubin, Albumin, L3-AFP, AFP, and DCP) to predict HCC prognosis. * **AFP-L3:** The lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) is more specific for HCC than total AFP. * **Fibrolamellar HCC:** Typically occurs in young adults without cirrhosis; notably, **AFP levels are usually normal** in these patients. * **CEA in Liver:** If a patient has a liver mass and elevated CEA, suspect **metastatic colorectal cancer** or **cholangiocarcinoma** rather than HCC.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free